| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.8 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.0096 | 0.8 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0087 | 0.8 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.8 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | 0.0094 | 0.8 |